Home » Stocks » AEMD

Aethlon Medical, Inc. (AEMD)

Stock Price: $2.67 USD 0.12 (4.71%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
Market Cap 31.28M
Revenue (ttm) 620,187
Net Income (ttm) -5.78M
Shares Out 12.07M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $2.67
Previous Close $2.55
Change ($) 0.12
Change (%) 4.71%
Day's Open 2.60
Day's Range 2.57 - 2.77
Day's Volume 568,926
52-Week Range 1.23 - 4.34

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 2 weeks ago

SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflamm...

PRNewsWire - 2 weeks ago

SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflamm...

InvestorPlace - 1 month ago

Aethlon Medical (AEMD) news for Wednesday concerning the progress in an EFS for one of its medical devices has AEMD stock soaring higher. The post Aethlon Medical News Alert: Why AEMD Stock Is...

PRNewsWire - 2 months ago

SAN DIEGO, Nov. 3, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening disea...

Seeking Alpha - 2 months ago

Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q2 2021 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

SAN DIEGO, Oct. 28, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threateni...

PRNewsWire - 3 months ago

SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue f...

PRNewsWire - 4 months ago

SAN DIEGO, Aug. 27, 2020 /PRNewswire/ -- Aethlon Medical, Inc.

Seeking Alpha - 5 months ago

Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q1 2021 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

SAN DIEGO, Aug. 11, 2020 /PRNewswire/ -- Aethlon Medical, Inc.

PRNewsWire - 5 months ago

SAN DIEGO, Aug. 4, 2020 /PRNewswire/ -- Aethlon Medical, Inc.

Seeking Alpha - 6 months ago

Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q4 2020 Results - Earnings Call Transcript

PRNewsWire - 6 months ago

SAN DIEGO, June 25, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threateni...

PRNewsWire - 7 months ago

SAN DIEGO, June 18, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflam...

Seeking Alpha - 11 months ago

Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q3 2020 Results - Earnings Call Transcript

24/7 Wall Street - 11 months ago

The story that has dominated this past week is that China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up.

Other stocks mentioned: INO, NNVC, NVAX
24/7 Wall Street - 11 months ago

China is facing an outbreak of the coronavirus, and more countries around the world are seeing cases pop up.

Other stocks mentioned: INO, NNVC, NVAX, SRPT
Benzinga - 11 months ago

Airlines, hotels, casinos and stocks linked to Wuhan, China, continue to fall as fear of the coronavirus deters international travel and all but halts activity in the virus epicenter.

Other stocks mentioned: APT, AZN, BCRX, CBLI, CERS, CODX, INO, LAKE, MRNA, NNVC, NVAX, VIR
Benzinga - 11 months ago

Shares of several vaccine makers were on the rise Tuesday following reports of a spreading coronavirus outbreak in Asia.

Other stocks mentioned: BCRX, INO, NVAX
Seeking Alpha - 1 year ago

Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Aethlon Medical, Inc. (AEMD) CEO Dr.

About AEMD

Aethlon Medical, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studi... [Read more...]

Industry
Medical Devices
CEO
Timothy Rodell
Employees
8
Stock Exchange
NASDAQ
Ticker Symbol
AEMD
Full Company Profile

Financial Performance

In 2019, AEMD's revenue was $650,187, an increase of 183.15% compared to the previous year's $229,625. Losses were -$6.37 million, 2.89% more than in 2018.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for AEMD stock is "Buy" and the 12-month stock price forecast is 7.00.

Price Target
$7.00
Analyst Consensus: Buy